LU87600A1 - Composes chimiques - Google Patents

Composes chimiques Download PDF

Info

Publication number
LU87600A1
LU87600A1 LU87600A LU87600A LU87600A1 LU 87600 A1 LU87600 A1 LU 87600A1 LU 87600 A LU87600 A LU 87600A LU 87600 A LU87600 A LU 87600A LU 87600 A1 LU87600 A1 LU 87600A1
Authority
LU
Luxembourg
Prior art keywords
fluorophenyl
formula
radical
imidazol
compound
Prior art date
Application number
LU87600A
Other languages
English (en)
French (fr)
Inventor
Nigel Stephen Watson
Chuen Chan
Barry Clive Ross
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888823191A external-priority patent/GB8823191D0/en
Priority claimed from GB888823192A external-priority patent/GB8823192D0/en
Priority claimed from GB898902847A external-priority patent/GB8902847D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of LU87600A1 publication Critical patent/LU87600A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU87600A 1988-10-03 1989-10-02 Composes chimiques LU87600A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB888823191A GB8823191D0 (en) 1988-10-03 1988-10-03 Chemical compounds
GB888823192A GB8823192D0 (en) 1988-10-03 1988-10-03 Chemical compounds
GB8823191 1988-10-03
GB8823192 1988-10-03
GB8902847 1989-02-09
GB898902847A GB8902847D0 (en) 1989-02-09 1989-02-09 Chemical compounds

Publications (1)

Publication Number Publication Date
LU87600A1 true LU87600A1 (fr) 1990-05-15

Family

ID=27264106

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87600A LU87600A1 (fr) 1988-10-03 1989-10-02 Composes chimiques

Country Status (19)

Country Link
US (2) US5013749A (it)
JP (1) JPH02188571A (it)
KR (1) KR900006297A (it)
AU (1) AU628862B2 (it)
BE (1) BE1003007A3 (it)
CH (1) CH680442A5 (it)
DE (1) DE3932887A1 (it)
DK (1) DK483689A (it)
ES (1) ES2019163A6 (it)
FI (1) FI894648A7 (it)
FR (1) FR2637183A1 (it)
GB (1) GB2223224B (it)
GR (1) GR890100634A (it)
IT (1) IT1237470B (it)
LU (1) LU87600A1 (it)
NL (1) NL8902441A (it)
NO (1) NO893909L (it)
PT (1) PT91878B (it)
SE (1) SE8903226L (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3913725A1 (de) * 1989-04-26 1990-10-31 Basf Ag 1-halogenvinyl-azole und diese enthaltende fungizide und wachstumsregulatoren
US5112819A (en) * 1989-10-10 1992-05-12 Glaxo Group Limited Imidazole derivatives, pharmaceutical compositions and use
JPWO2002030425A1 (ja) * 2000-10-12 2004-02-19 日産化学工業株式会社 糖尿病合併症予防・治療剤
EP1389107A4 (en) * 2001-04-27 2005-10-12 Bristol Myers Squibb Co BISARYLIMIDAZOLYL-FATTY ACID AMIDE-HYDROLASE INHIBITORS
BRPI0509926A (pt) * 2004-04-16 2007-09-18 Warner Lambert Co imidazóis
US20050272770A1 (en) * 2004-04-29 2005-12-08 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
EP1755607A2 (en) * 2004-04-29 2007-02-28 Pharmix Corporation Compositions and treatments for inhibiting kinase and/or hmg-coa reductase
US7163945B2 (en) * 2004-04-29 2007-01-16 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20050282883A1 (en) * 2004-04-29 2005-12-22 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20060084695A1 (en) * 2004-04-29 2006-04-20 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7199126B2 (en) * 2004-04-29 2007-04-03 Pharmix Corporation Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7183285B2 (en) * 2004-04-29 2007-02-27 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20060111436A1 (en) * 2004-11-23 2006-05-25 John Griffin Compositions and treatments for modulating kinase and/or HMG-CoA reductase
US8372877B2 (en) 2010-04-16 2013-02-12 Cumberland Pharmaceuticals Stabilized statin formulations
JPWO2012046772A1 (ja) 2010-10-06 2014-02-24 国立大学法人 東京大学 リンパ浮腫予防治療剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
AU598775B2 (en) * 1985-10-25 1990-07-05 Sandoz Ag Heterocyclic analogs of mevalonolactone
JPS6322056A (ja) * 1986-04-30 1988-01-29 サンド・アクチエンゲゼルシヤフト オレフイン性化合物の製造法
DE3800785A1 (de) * 1988-01-09 1989-07-20 Hoechst Ag Substituierte 7-(pyridazin-5-yl)-3,5-dihydroxyheptan(en)- saeuren, ihre entsprechenden (delta)-lactone bzw. derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
NO890522L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte imidazolinoner og imidazolinthioner.

Also Published As

Publication number Publication date
GR890100634A (el) 1990-11-29
US5120848A (en) 1992-06-09
BE1003007A3 (fr) 1991-10-22
NO893909L (no) 1990-04-04
IT8948424A0 (it) 1989-10-02
NL8902441A (nl) 1990-05-01
FI894648L (fi) 1990-04-04
IT8948424A1 (it) 1991-04-02
FI894648A7 (fi) 1990-04-04
US5013749A (en) 1991-05-07
KR900006297A (ko) 1990-05-07
IT1237470B (it) 1993-06-07
FR2637183A1 (fr) 1990-04-06
FI894648A0 (fi) 1989-10-02
GB2223224B (en) 1992-01-08
DK483689D0 (da) 1989-10-02
NO893909D0 (no) 1989-10-02
DK483689A (da) 1990-04-04
GB8922212D0 (en) 1989-11-15
SE8903226D0 (sv) 1989-10-02
JPH02188571A (ja) 1990-07-24
AU4243189A (en) 1990-04-05
SE8903226L (sv) 1990-04-04
AU628862B2 (en) 1992-09-24
ES2019163A6 (es) 1991-06-01
DE3932887A1 (de) 1990-04-05
CH680442A5 (it) 1992-08-31
PT91878A (pt) 1990-04-30
GB2223224A (en) 1990-04-04
PT91878B (pt) 1995-05-31

Similar Documents

Publication Publication Date Title
JP3316661B2 (ja) 〔（ヒドロキシフェニルアミノ）カルボニル〕ピロール
MC1241A1 (fr) Derives de l'imidazole et leur preparation et preparation de medicaments contenant ces substances
WO2010130945A1 (fr) Dérivés de 7-aza-spiro[3.5]nonane-7-carboxylates, leur prépraration et leur application en thérapeutique
US5013749A (en) Imidazole derivatives and their use as hypercholesterolemia and hyperlipoproteinemia agents
LU85796A1 (fr) Derives antipsychotiques de la 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine
EP2429998B1 (fr) Dérivés de cyclopenta[c]pyrrolylalkylcarbamates d'hétérocycles à 5 chaînons, leur préparation et leur application en thérapeutique
LU85551A1 (fr) Nouveaux composes azoliques,leur preparation et leur utilisation comme antifongiques et fongicides
EP1546111A2 (fr) Composes derives de la 2-thiohydantoine et leur utilisation pour le traitement du diabete
FR2552759A1 (fr) Composes de la 1,2,4-triazolone et leur application pharmacologique
JPH08823B2 (ja) 血糖低下性チアゾリジンジオンとその中間体
EP1611127A2 (fr) Derives de quinoleines-4-substituees avec une activite antimicrobienne
WO2005077898A1 (fr) Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique
HUT71347A (en) Novel process for preparing chiral {[(2-bromoethyl)-amino]-methyl}-2-nitro-1h-imidazol-1-ethanol and related compounds
FR2626175A1 (fr) Composes nouveaux de 1,2-ethylenediamine et composition pharmaceutique les contenant
CA2296725C (fr) Polyhydroxybutylpyrazines, leur preparation et les medicaments les contenant
EP1720829B1 (fr) Derives d' heteroaryl-alkylcarbamates, leur preparation et leur application comme inhibiteurs de l'enzyme faah
US5055484A (en) 7(1h-pyrrol-3-yl)-substituted 3,5-dihydroxyhept-6-enoic acids, 7-(1h-pyrrol-3-yl)-substituted 3,5-dihyroxyhept-anoic acids, their corresponding delta-lactones and salts, their use as medicaments and pharmaceutical products and intermediates
US5112819A (en) Imidazole derivatives, pharmaceutical compositions and use
US4985427A (en) Triazine derivatives
JP2630877B2 (ja) 光学活性なトリアゾール誘導体および組成物
EP1551821B1 (fr) Derives de 3-(cyclopenten-1-yl)-benzyl- ou 3-(cyclopenten-1-yl)-heteroarylmethyl-amines et leur utilisation a titre de medicaments pour le traitement de la schizophrenie
FR2830862A1 (fr) Derives nitroso de la diphenylamine a fonction ether ou thioether, compositions pharmaceutiques les contenant et leur utilisation pour la preparation de medicaments
LU86443A1 (fr) Nouveaux compoes azoliques,leur preparation et leur utilisation comme antifongiques et fongicides
WO2003011856A1 (fr) Derives d'aminoalkylimidazole, leur preparation et leur utilisation en therapeutique
WO2018042096A1 (fr) Derives de 2-quinoline-2-one en tant que modulateurs de recepteurs nmda, compositions les comprenant et utilisation de ces composes dans le traitement de maladies impliquant le systeme nerveux central